Tris Pharma Announces Availability of New DYANAVEL® XR (amphetamine) Tablets for ADHD

/PRNewswire/ -- Tris Pharma, Inc. (Tris) a fully integrated pharmaceutical company with a robust portfolio of CNS products announced today that DYANAVEL® XR...

Related Keywords

James Hackworth ,Tris Pharma Inc ,Drug Administration ,Neuroscience Education Institute ,Pharma Inc ,Tris Branded Products Division ,Attention Deficit Hyperactivity Disorder ,Permanent Product Measure ,Performance Total ,Clinical Psychiatry ,Clin Psychiatry ,Clinical Associate Professor ,Upstate Medical ,Tris Branded Products ,Boxed Warning ,Tris Pharma ,Nc ,